NGM·Healthcare·$140M·#27 / 520 in Healthcare
STIM Neuronetics, Inc.
75SOLID
CATEGORY BREAKDOWN
GROWTH100
QUALITY81
STABILITY39
VALUATION100
GOVERNANCE89
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+99.2%
100
> 50% strong
Gross Margin
Revenue retained after direct costs
48.5%
68
> 50% strong
Cash Runway
Months of cash at current burn rate
17 months
59
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
403.5%
0
< 25% strong
Price / Sales
Market cap relative to trailing revenue
0.9x
100
< 3x strong
Rule of 40
Growth rate plus operating margin
78
100
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
31.4%
100
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+5.7%
66
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE STIM WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when STIM's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.